Jane Street
STRO icon

Jane Street’s Sutro Biopharma STRO Stock Holding History

Jane Street’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$692K Buy
27,760
+4,815
+21% +$87K ﹤0.01% 7294
2025
Q4 		$265K Buy
+22,945
New +$218K ﹤0.01% 9106
2025
Q3 		– Sell
-68,885
Closed -$492K – 11733
2025
Q2 		$492K Buy
+68,885
New +$563K ﹤0.01% 6951
2024
Q4 		– Sell
-10,819
Closed -$374K – 10546
2024
Q3 		$374K Buy
10,819
+2,541
+31% +$99.6K ﹤0.01% 7683
2024
Q2 		$243K Buy
8,278
+814
+11% +$32.2K ﹤0.01% 8126
2024
Q1 		$422K Sell
7,464
-3,105
-29% -$137K ﹤0.01% 6983
2023
Q4 		$453K Buy
10,569
+9,241
+696% +$293K ﹤0.01% 6927
2023
Q3 		$46.1K Sell
1,328
-13,268
-91% -$578K ﹤0.01% 8169
2023
Q2 		$679K Buy
+14,596
New +$727K ﹤0.01% 5842
2023
Q1 		– Sell
-1,755
Closed -$142K – 9901
2022
Q4 		$142K Buy
+1,755
New +$122K ﹤0.01% 7902
2021
Q2 		– Sell
-2,240
Closed -$510K – 10386
2021
Q1 		$510K Buy
+2,240
New +$532K ﹤0.01% 6769

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jane Street's STRO Position: Q1 2026 in Review

Jane Street increased its Sutro Biopharma (STRO) stake by 21% in Q1 2026, buying an estimated $87K and bringing the position to 27,760 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #7294.

Jane Street first reported a position in STRO in Q1 2021 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Jane Street held 27,760 shares of Sutro Biopharma worth $692K as of Q1 2026.
  • Jane Street bought 4,815 Sutro Biopharma shares in Q1 2026, an estimated $87K.
  • Sutro Biopharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7294 holding.
  • Jane Street first reported a position in Sutro Biopharma in Q1 2021 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.